Kendall Capital Management »

Amneal Pharmaceuticals shares owned by Kendall Capital Management

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Kendall Capital Management from 13F filings

Historical chart of Kendall Capital Management investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Kendall Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Kendall Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $432k 34k 12.60
2025-09-30 $257k 26k 10.01
2025-06-30 $155k 19k 8.09

More positions owned by Kendall Capital Management

iShares Russell 2500 ETF Rusel 2500 Etf (SMMD)
T. Rowe Price Small-Mid Cap ETF Small Mid Cap (TMSL)
JPMorgan International Research Enhanced Equity ETF Intrnl Res Eqt (JIRE)
Broadcom (AVGO)
Vanguard Growth Index Fund ETF Growth Etf (VUG)
Vanguard Emerging Markets Stock ETF Ftse Emr Mkt Etf (VWO)
JPMorgan Ultra-Short Income ETF Ultra Shrt Etf (JPST)
Avnet (AVT)
Omni (OMC)
VSE Corporation (VSEC)
Dell Technologies CL C (DELL)
KLA Corp Com New (KLAC)
Vanguard Large-Cap ETF Large Cap Etf (VV)
Celestica (CLS)
Alphabet Inc A Cap Stk Cl A (GOOGL)

View all positions for Kendall Capital Management

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Assenagon Asset Management
Neuberger Berman Group
Millennium Management
Nuveen
Goldman Sachs Group
Nantahala Capital Management
BlackBarn Capital Partners

View all funds holding Amneal Pharmaceuticals